Abstract Submission Rules & Guidelines
Online abstract submission is now closed.
All abstracts will be published in a supplement of Osteoporosis International and an issue of Journal of Clinical Densitometry.
Deadline: November 4, 2013 at 23:59 UTC-6
- All abstracts for the Meeting must be submitted using the online abstract submission system.
- Submission by fax, e-mail or courier will not be accepted.
- While delegates may indicate their preference for oral or poster presentation, the final decision is made by the scientific program committee. While every attempt will be made to program abstracts according to the requests of authors, requests for oral presentations cannot be guaranteed.
- All submitted abstracts must contain original data in order for it to be published.
- IOF and ISCD are not responsible for errors in the abstract submission. Read your text to ensure accuracy with no spelling, grammatical or scientific errors. No corrections will be accepted after the abstract submission deadline. IOF and ISCD will not translate any abstract. It will be published, if accepted, as submitted in English.
- Submission of an abstract constitutes a formal commitment by the presenting author to attend the Meeting and present the abstract (if accepted) orally or as a poster in the session and at the time assigned by the scientific program committee.
- Expenses associated with the preparation, submission and presentation of an abstract are the responsibility of the presenting authors.
- All submitting authors must consent to the Declaration Statement on behalf of her/his coauthors in order for the abstract to be accepted for submission. This includes the certification that any work with human or animal subjects related in this abstract complies with the guiding principles for experimental procedures as set forth in the Declaration of Helsinki and related publications.
Organization and Content
Please read this information carefully
- Abstracts will be published in a supplement of Osteoporosis International and an issue of Journal of Clinical Densitometry (only if accepted).
- For standardization, the total length of the abstract must not exceed 3000 printable characters (these include nonvisible characters such as spaces) and 70 line counts.
- The body of the abstract will be structured as follows with the following subtitles:
- References (if applicable)
- Acknowledgments (if applicable)
- Images may be included with the following criteria:
- Minimum image resolution: 300 dpi
- Maximum image width: 8 cm
- Allowed file types: .gif, .jpg
- Commercial (trade) names of drugs are not allowed – the generic or chemical names must be used.
- Please be advised that the insertion of images may significantly reduce the number of remaining characters, because these will be included in the character and line count. It is highly recommended to use only one image to allow for enough abstract text.
- The abstract Title should clearly define the content of the paper.
- It is preferable that the Aim is stated in one sentence, the Methods kept to a brief description, that the Results are summarized and presented in sufficient detail to support the Conclusions. Note that it is not recommended to postulate that “the results will be discussed during the oral presentation” or that “other data will be presented later”.
- Images will be published in color when applicable with a printed width of approximately 8 cm. Please refer to the online abstract submission platform for further details regarding abstract content and style, including submission of Greek characters, tables and figures. Note that copy-pasting is enabled with automatic update of the font style.
- Use standard abbreviations where appropriate. Include any other abbreviations in brackets after the full word the first time it appears.
- Number and list References (if applicable) in the order in which they appear in the abstract, within the 3000 characters limit.
- All Acknowledgements to grants, funding source or other coworkers will appear at the bottom of the abstract and shall be included in the 3000 characters limit.
- Please enter a maximum of two keywords, one per each box available, and double check the spelling of the entered keywords.
Disclosure of Conflict of Interest
All submitting authors must disclose, on behalf of all other authors of the abstracts, any conflicts of interest during the online abstract submission or have their work refused at the discretion of the organizing committee. All disclosures will be available.
When you submit your abstract online, you will be asked to indicate if the authors now or in the past 12 months have had a significant financial interest or other relationship with commercial companies or other entities whose products or services you may discuss in your presentation, or who are supporting this activity. For any of the following relationship categories that apply to each author, you will be asked to indicate the relationship and name the commercial entities involved:
- grant/research support
- consultant/speaker's bureau/advisory activities
- board membership
- company employee
- stock ownership or royalties
- patent licensing
We request all presenters to cooperate by declaring any potential conflict of interest on their slides or posters.
Editing and Withdrawal
All abstracts may be edited or withdrawn by going through the online abstract submission system prior to November 4, 2013. However, abstracts may not be withdrawn after November 4, 2013 unless an acceptable explanation is received in writing by the organizers. An example of an acceptable explanation would be the inability to reproduce the data described in the abstract.
Abstract Receipt Confirmation
The final step of the online submission process generates a confirmation email that your abstract has been received, which you should print for your personal record. The confirmation email represents the successful submission of an abstract for the review process.
All abstracts will be subjected to a single blind review process by a panel of international experts in the field. Mean scores will be calculated for each abstract and based on this they will be allocated to oral or poster presentations, or they may be rejected. Each abstract will be scored based on the following criteria: scientific merit, suitable sample size, proper statistical analysis, adherence to instructions and originality of the work.
Abstract Assignment Notification
Presenting authors will be notified by e-mail by end of November 2013 if their abstract has been accepted. Date, time and type of their presentation will be confirmed. It is the responsibility of the presenting author to notify the other co-authors of the outcome decision. IOF, ISCD and the scientific program committee do not correspond on the reasons of acceptance/rejection of an abstract. Instructions for oral presentation and poster preparation will be e-mailed in due course to the presenting authors.
A publication and media embargo is in force for each abstract to be presented at the IOF-ISCD Skeletal Health Orlando 2014 Meeting and will be lifted one hour after the abstract has been presented. If study results are reported prior to the embargo date, the abstract is subject to penalties, including removal from the Meeting program. This embargo policy covers all abstracts accepted as part of the IOF-ISCD Skeletal Health Orlando 2014 Meeting, regardless of whether information is obtained from another source.